Onconetix, Inc. Amortization
Onconetix, Inc. (ONCO) reported Amortization of -$595.76 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2024-12-10
- Onconetix, Inc. amortization for the quarter ending 2024-09-30 was -$198.17K.
- Onconetix, Inc. amortization for the quarter ending 2024-06-30 was -$195.99K.
- Onconetix, Inc. amortization for the quarter ending 2024-03-31 was -$201.59K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month |
|---|---|---|---|
| 2024-09-30 | -$198.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | -$394.17K derived: sum of 2 quarters · filed 2024-12-10 | -$595.76K 10-Q · filed 2024-12-10 |
| 2024-06-30 | -$195.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-29 | -$397.59K 10-Q · filed 2024-08-29 | |
| 2024-03-31 | -$201.59K 10-Q · filed 2024-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |